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Wounds to the skin heal via a complex series of overlapping tightly regulated phases. With increas ing age these become disrupted, and repair effi ciency is reduced. Chronically impaired healing in the elderly is a major area of unmet clinical need that constitutes a substantial drain on global health services and leads to significant patient morbidity. In women the transition to delayed healing coin cides with menopause, where hormone levels, particularly estrogen, rapidly fall. We have previ ously reported that estrogen replacement substan tially accelerates healing in both aged humans and estrogendepleted animal models (Ashcroft et al., 1997) . Moreover, estrogen protects against the development of chronic nonhealing wounds (Margolis et al., 2002) . We currently believe es trogen to be a key pleiotropic factor (Emmerson et al., 2009) , beneficially influencing a range of cutaneous cell types involved in multiple aspects of wound repair including inflammation, re epithelialization, angiogenesis, matrix deposition, and remodelling. In fact, at the level of gene ex pression, estrogen appears more important than intrinsic ageing in the ontogenesis of pathological repair (Hardman and Ashcroft, 2008) . Unfortu nately, recent research has highlighted the poten tial detrimental impact of longterm hormone replacement therapy (HRT) use, namely an in creased risk of breast cancer, stroke, and coronary heart disease (Anderson et al., 2004) . Thus, there is a fundamental need to further elucidate cutane ous estrogen signaling with a view to selectively exploit the beneficial aspects to promote healing.
Post-menopausal women have an increased risk of developing a number of degenerative pathological conditions, linked by the common theme of excessive inflammation. Systemic estrogen replacement (in the form of hormone replacement therapy) is able to accelerate healing of acute cutaneous wounds in elderly females, linked to its potent antiinflammatory activity. However, in contrast to many other age-associated pathologies, the detailed mechanisms through which estrogen modulates skin repair, particularly the cell type-specific role of the two estrogen receptors, ER and ER, has yet to be determined. Here, we use pharmacological activation and genetic deletion to investigate the role of both ER and ER in cutaneous tissue repair. Unexpectedly, we report that exogenous estrogen replacement to ovariectomised mice in the absence of ER actually delayed wound healing. Moreover, healing in epidermal-specific ER null mice (K14-cre/ER L2/L2 ) largely resembled that in global ER null mice. Thus, the beneficial effects of estrogen on skin wound healing are mediated by epidermal ER, in marked contrast to most other tissues in the body where ER is predominant. Surprisingly, agonists to both ER and ER are potently antiinflammatory during skin repair, indicating clear uncoupling of inflammation and overall efficiency of repair. Thus, estrogen-mediated antiinflammatory activity is not the principal factor in accelerated wound healing.
RESULTS AND DISCUSSION ER isoform-selective agonists confer contrasting effects on skin repair
In light of severely limited mouse ER expression data in the literature we first profiled receptor localization in mouse skin. We report that both receptors are widely expressed, with immunohistochemical localization to keratinocytes, hair follicles, fibroblasts, and endothelial and inflammatory cells ( Fig. S1 ). To address the independent contribution of each receptor to skin repair we systemically treated estrogendeprived mice with agonists specific for ER or ER and generated incisional wounds. After 3 d the degree of in vivo repair was quantified with respect to ovariectomised (Ovx) mice ( Fig. 1 , A-C). DPN (a 70fold selective ER agonist) significantly reduced wound area, to a level comparable with that of 17 estradiol, simultaneously promoting restoration of the epi dermis. In stark contrast, signaling through ER (PPT treatment; 410fold selective ER agonist) had no effect on these global measures of healing.
Intriguingly, both agonists were equally antiinflammatory with respect to wound macrophage and neutrophil recruit ment ( Fig. 1 , D-F). ERmediated effects on inflammation are important for numerous other body systems: the ER ag onist PPT is both neuroprotective and antiinflammatory in neurodegenerative disorders such as Alzheimer's disease (TiwariWoodruff et al., 2007) ; ER mediates the pro tective effect of estrogen on skin necrosis in a skin flap per fusion model (Toutain et al., 2009) . Notably, in the brain ER agonist treatment has no antiinflammatory effects (TiwariWoodruff et al., 2007) , although Toutain et al. (2009) unfortunately failed to investigate the role of ER in their skin flap model. Our agonist treatment data show that although signaling through ER alone is sufficient to re duce skin inflammation in vivo, as widely reported in other tissues, it does not accelerate wound repair. Thus, we identify a clear uncoupling of inflammation and repair in the context of ER signaling. Current thinking would suggest a tightly regulated inflammatory response is essential to appropriate repair, with either excessive inflammation (chronic wounds) or macrophage ablation leading to delayed healing (Mirza et al., 2009 ).
ER null mice display a profound wound-healing phenotype
The next logical step was to investigate the effect of ER specific deletion. Thus, incisional wounds were generated in wildtype (WT), ER null (ER / ), and ER null (ER / ) mice, in the absence of estrogen (Ovx) or after ex ogenous estrogen replacement (Ovx plus s.c. 17estradiol pellet). Healing was delayed in the absence of estrogen in all three genotypes ( Fig. 2 , A, C, and D), implying a limited role for ER signaling in the absence of a ligand. However, upon exogenous estrogen replacement a clear genotypespecific response was revealed, with ER / wounds substantially increased in size (Fig. 2 , A-C). Delayed healing in ER / corroborates our ER isoformspecific agonist treatment data ( Fig. 1; where DPNmediated acceleration indicates the In both mice and humans, estrogen signals through two related but distinct nuclear hormone receptors, es trogen receptor (ER)  and , which function as either homo or heterodimers. The receptors, which share >95% homology in their DNAbinding domain, are differen tially expressed throughout mammalian tissues (for review see DahlmanWright et al., 2006) . In human skin ER iso form distribution reportedly varies depending on cell type, source, and time: ER is suggested to be the predominant isoform in human scalp keratinocytes (Thornton et al., 2003b) ; although other studies describe both receptors in neonatal foreskinderived keratinocytes (VerdierSevrain et al., 2004) , dermal fibroblasts (Haczynski et al., 2004) , and hair follicles and sebaceous glands (Thornton et al., 2003a) . Despite detailed knowledge of human skin ER distri bution, but curiously not mouse, understanding of the role that each receptor plays in cutaneous healing is se verely lacking.
Agonists selective for each estrogen receptor are cur rently being used in vivo to elucidate the specific roles of ER isoforms in a range of tissues. In addition, several iter ations of ER null mice have been generated, each improv ing upon the previous, after initial issues with lack of splice variant deletion (for review see Antal et al., 2008) . These mice have been extensively characterized with phenotypes reported in a range of tissues. Both ER / and ER / mice display pronounced reproductive phenotypes (for re view see Couse and Korach, 1999) . In peripheral tissues, however, ER appears to predominate, with ER / mice displaying abnormalities in mammary, bone, neurological, vascular, metabolic, and other tissues. Thus, although ER is clearly of fundamental physiological importance, the re spective role of ER is more contentious. Despite numer ous reports describing pathological phenotypes in global ER / mice (for review see Couse and Korach, 1999) , a recently generated constitutiveCre ER( L/L ) null mouse appears virtually devoid of peripheral tissue pathology (Antal et al., 2008) .
The limited data that does exist on the role of ERs in the skin is mostly based around studies of hair biology. In male mice, hair cycling appears mediated by ER, whereas catagen transition is ER regulated (Movérare et al., 2002; Ohnemus et al., 2005) . Recently the protective effect of es trogen on skin flap necrosis has been reported to be mediated by ER (Toutain et al., 2009 ). To date, however, no study has investigated the effect of ERspecific deletion, or the role of ER isoforms in skin wound healing in female mice. In this study, using a combination of in vivo and in vitro methodologies, we demonstrate very different roles for the two ERs during skin wound healing. Specifically, the benefi cial effects of estrogen in skin are mediated through ER, with signaling through ER alone having a detrimental in fluence on repair. To our knowledge, skin healing is unique in that it is the first tissue where; (a) ERs have been demon strated to have such clearly opposed physiological effects and (b) ERmediated influence is so predominant.
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Estrogen is potently antiinflammatory in WT mice, in hibiting local wound recruitment of innate immune cells in vivo (Fig. 2 , E-H) and dampening lipopolysaccharide induced cytokine production in vitro (Emmerson et al., 2009 ). Immunohistochemical characterization of wound cell infil trate in ER null mice revealed key quantitative differences in local inflammation. Estrogen replacement in ER / mice failed to dampen inflammation, whereas ER / mice were characterized by a significant and specific increase in wound neutrophils (Fig. 2 , E-H). It is generally accepted that excessive neutrophil infiltration plays a causative role in patho logically delayed healing; however, the role of macrophages importance of ER). Mechanistically, estrogen can modulate keratinocyte, fibroblast, and inflammatory cell functions. Thus, delayed healing in estrogentreated ER / mice may reflect defective wound contraction, delayed reepithelialization, ex cessive inflammation, altered angiogenesis, or a combination of these processes. provide an additional new model to investi gate such yinyang ER interactions.
Delayed healing in global ER / is recapitulated in epidermal-specific ER null mice in the absence of excessive inflammation
Estrogen is a known keratinocyte mitogen (Emmerson et al., 2009 ), yet paradoxically, neither ER / nor ER / mice dis played increased reepithelialization after estrogen treatment (Fig. 2 D) . Mouse keratinocytes express both ERs (Fig. S1 ) with a recent report indicating that agonists specific for either ER can promote the in vitro migration of the human keratino cyte cell line NCTC 2544 (Merlo et al., 2009) . To further investigate mouse epidermal ER function we wounded epidermalspecific (K14cre) knockout mice, K14-cre/ER L2/L2 (K14ER), K14-cre/ER L2/L2 (K14ER), and WT litter mates. Estrogen treatment of Ovx K14ER mice led to pro nounced and significant acceleration of reepithelialization ( Fig. 3 C) . In contrast, estrogen treatment of Ovx K14ER mice failed to promote reepithelialization (Fig. 3 C) and led to a significant delay in overall healing (Fig. 3, A and B ). Com parison of the temporal healing profile between estrogen treated K14ER and WT mice shows that the observed difference in repair at d 3 after wounding is maintained over subsequent stages of healing ( Fig. 3 D) . That K14ER mice essentially phenocopy global ER / mice indicates estrogen's beneficial influence on healing is predominantly mediated by epidermal ER, and presumably involves paracrine signal ing to additional cell types (e.g., vascular, fibroblast) that also functionally influence the healing response.
In this context it is interesting to draw comparisons to other tissues where complex stromal-epithelial interactions occur, such as mammary gland or prostate. The mammary gland un dergoes highly orchestrated morphological change during de velopment and pregnancy, for which epithelial-mesenchymal appears more subtle (Diegelmann, 2003) . Recent studies have revealed macrophages to be beneficial only at specific stages of tissue repair (Mirza et al., 2009) . It is tempting to speculate that increased neutrophil numbers could play a role in the delayed healing of the ER / mouse phenotype.
Collectively, these in vivo data strongly suggest that sig naling though ER in the absence of ER is in fact detri mental to healing. Moreover, we observed marked differences between agonisttreated mice (allowing ER heterodimeriza tion) and ER null mice (exclusively ER homodimers). For example, the ER agonist DPN strongly promoted re epithelialization in vivo (Fig. 1) , whereas estrogen treatment of ovariectomised ER / mice (Fig. 2) did not alter re epithelialization. Thus, signaling through ER leads to en tirely different phenotypes depending on the presence or absence of ER. This implies that a proportion of skin ER mediated effects are through ER inhibition or alternatively that ER heterodimers are physiologically important. Such "yinyang" ER interactions have been classically described in cancer, which is fascinating as clear analogies have been drawn between cancer progression and tissue repair (Dvorak, 1986) . ER classically promotes tumor proliferation through regulation of the cell cycle, whereas ER is antiproliferative (Paruthiyil et al., 2004) . Indeed, it has been proposed, but not shown, that many of the physiological effects of ER in other tissues are in fact due to direct antagonistic effects on ER mediated transcription (Lindberg et al., 2003) . Skin could 
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In our primary keratinocytes both 17estradiol and DPN, but not PPT, significantly increased adhesion to noncoated (Fig. 4 C) and collagen coated (unpublished data) tissue culture plates. Interestingly, the migration/adhesion effects are proliferation independent, as proliferation rate is not influenced by either 17estradiol or ER agonists (Fig. 4 D) .
ER isoforms differentially regulate fibroblast migration in vitro
Fibroblasts represent an excellent candidate cell type for nonkeratinocytemediated effects of ERs on wound heal ing, with estrogen known to influence multiple skin fibro blast functions (Emmerson et al., 2009 ). As the observed in vivo delayed healing phenotype in ER / mice (Fig. 2) involved substantial wound gaping, we asked whether ER mediated effects on fibroblast contraction could be involved. In a cellbased contraction assay 17estradiol, DPN, or PPT treatment all inhibited collagen disc contraction ( Fig. 5 A) , suggesting that signaling through ER versus ER was un likely to differentially alter contraction in vivo. Moreover, equal numbers of smooth muscle actin (SMA)-positive cells were observed in WT and global ER / and ER / wounds in vivo ( Fig. 5 B) . Although these data suggest minimal in volvement of fibroblastmediated contraction, the observed phenotype (wound gaping) does suggest inherent differences in tensional forces upon wounding. Wound contraction is a complex process that is also affected by numerous factors, for example balance between collagen synthesis and deposi tion, and thus early changes may be involved in the ob served phenotype.
We have previously shown that 17estradiol treatment accelerates WT mouse fibroblast migration in vitro (Emmerson et al., 2009 ). The ER agonist DPN also substantially accel erated in vitro scratch assay migration, whereas the ER agonist PPT had no significant effect (Fig. 5, C and D) . Receptorspecific function was confirmed by cotreatment with 17estradiol and ERspecific antagonists ( Fig. 5 D) ; blocking both ERs (ICI) abolished estrogenpromoted migration; specifically blocking ER (MPP) led to dramati cally accelerated migration (> twofold increase), whereas specifically blocking ER (PHTPP) had no significant effect on estrogen's migration promoting ability. As in keratino cytes, these treatments had no effect on fibroblast prolifera tion ( Fig. 5 E) , indicating that altered proliferation does not contribute to the migrationpromoting effects of 17estradiol cross talk is absolutely essential. ER null mouse experi ments indicate that ER triggers ductal growth, whereas ER is involved much later in terminal differentiation. In terestingly, although ER expression in mammary epithe lium is heterogeneous, estrogen induces proliferation in all epithelial cells, implying paracrine effects on ERnegative epithelial cells (Mallepell et al., 2006) . Amphiregulin, an EGF receptor ligand, is a prime candidate for mediating these effects in vivo. Similar keratinocyte-keratinocyte and keratinocytefibroblast interactions almost certainly occur during skin wound healing, where EGF/FGF receptors play a welldocumented role. However, our data suggest that ER is the key player in these epithelial-mesenchymal events.
Fascinatingly, the inflammatory response in delayedhealing wounds from epidermalspecific K14ER mice appeared equivalent to that in WT mice (Fig. 3, E and F) . That K14 ER mice display delayed healing concomitant with reduced inflammation provides yet more evidence for uncoupling of inflammation and healing. Moreover, this phenotype strongly suggests that inflammatory cell changes (i.e., increased neu trophil infiltration) are not a principal causative factor in de layed healing in global ER / mice (Fig. 2 H) . To investigate this further we wounded mice with LysMcre-mediated in flammatory cellspecific deletion of ER (Fig. S2) . These mice were essentially phenotypically normal with reduced wound area and dampened inflammation in response to es trogen treatment. This strongly implies that inflammatory cellspecific ER does not contribute to the global ER / delayed wound healing phenotype, reinforcing the impor tance of keratinocyteexpressed ER in estrogen's beneficial effects on wound healing.
To further clarify the role of each ER in keratinocyte function we performed in vitro scratch wound migration assays. Treatment of WT keratinocytes with the ER agonist DPN promoted migration, whereas the ER agonist PPT had no influence on scratch wound closure (Fig. 4, A and B) . These data fit perfectly with in vivo agonist treatment (Fig. 1 D) and epidermalspecific ER deletion data (Fig. 3 C) . It is unclear why Merlo et al. (2009) report enhanced in vitro migration in response to both PTT and DPN. They used a cell line, whereas we used more physiologically relevant primary keratinocytes. in chronic wounds, and play an important role in granula tion tissue remodelling (Wysocki et al., 1993) . Though we have previously reported increased MMP9 protein levels in delayedhealing Ovx mouse wounds (Emmerson et al., 2009 ), we have not explored the effect of in vivo 17estradiol treat ment on wound protease activity. Collectively, these data suggest that inappropriately excessive local gelatinase activity is a principal contributing factor to reduced collagen deposi tion and delayed wound healing in ER / mice. However, the phenotypes of estrogentreated LysMER (Fig. S2) and K14ER (Fig. 3) mice suggests that increased inflammation and protease activity in estrogentreated ER / mice is in fact secondary to delayed healing (i.e., noncausative), once again indicating complex paracrine interactions. Of note, by d 7 after wounding this ERspecific difference in collagen deposition, assessed by PicroSirius red staining, was no longer apparent (unpublished data), indicating the observed d 3 phenotype is due to an extended lagphase of healing in the ER / mice (see also Fig. 3 D) , possibly due to differ ences in wound contraction (see Fig. 5 ).
In summary, our novel data reveal the beneficial effects of estrogen on skin healing to be predominantly mediated though keratinocyte ER (Fig. S3 ). This fascinating finding appears at odds with the recent suggestion that ER / mice display relatively few global phenotypic abnormalities (Antal et al., 2008) . Indeed, we suggest that the role of ER may be revealed only in response to perturbation of homeostasis or in pathophysiological conditions. Limited previous stud ies have suggested that ER plays a predominant role in the skin (Toutain et al., 2009) . That ER has been identi fied as the major player during skin repair further corrobo rates previous reports linking specific human ER gene polymorphisms with predisposition to chronic nonhealing wounds (Ashworth et al., 2008) . In light of the detrimental sideeffects of estrogen treatment in postmenopausal women, specifically increased cancer incidence, there is cur rently much interest in the development of estrogenic alter natives. Selective estrogen receptor modulators (SERMs) have been, and are currently being, developed that differen tially bind ERs with tissuespecific agonist/antagonist pro files. In fact, we have recently demonstrated the potential of clinically relevant SERMs (tamoxifen and raloxifene) to ac celerate wound repair in vivo. The novel findings from this study are of fundamental importance and should now permit the development of strategies to selectively exploit benefi cial ERmediated signaling events to accelerate wound healing in the elderly.
MATERIALS AND METHODS

Animals and wounding.
All animal studies were approved by the UK Government Home Office (Project licence 40/3203) following local ethics committee approval. ER / (Esr1) and ER / (Esr2) have been described previously (Dupont et al., 2000) . Novel conditional ER null mice were generated as follows. Epidermalspecific deletion of ER and ER was ob tained by crossing the previously described ER L2/L2 (Dupont et al., 2000) and ER L2/L2 (Antal et al., 2008) mice with the extensively characterized K14cre line (Li et al., 2001) . Inflammatory cellspecific deletion was or DPN. Thus, promotion of fibroblast migration may contribute to the observed accelerated healing in DPN treated mice (Fig. 1) .
Excessive protease activity and reduced matrix deposition contribute to delayed healing in estrogen-treated ER / mouse wounds Altered systemic hormone levels have been linked to changes in skin collagen deposition and turnover during wound heal ing (Gilliver et al., 2007) . In light of clear ERspecific effects on fibroblast function, we next assessed aspects of wound matrix synthesis, deposition, and remodeling (Fig. 6) . We demonstrate reduced gene expression of the major skin collagen species in delayedhealing estrogentreated ER / wounds ( Fig. 6 A) accompanied by greatly reduced wound collagen protein deposition/remodelling, assessed via PicroSirius red staining (Fig. 5 B) . Of mechanistic importance, we show that the spe cific increase in wound neutrophil influx in estrogentreated ER / wounds is accompanied by an increase in inflamma tory cell gelatinase expression and crucially wound gelatinase activity (Fig. 5, C and D) . Gelatinases (MMP2 and MMP9) are induced after wounding, are pathologically overexpressed 
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Gelatin zymography. Total protein was extracted from mouse wound tissue using denaturing, nonreducing buffer. 50 µg protein was assessed for gelatinase activity, as described previously (Gilliver et al., 2007) . In brief, sam ples were separated by SDSPAGE alongside human MMP2 and MMP9 reference standards. Gels were washed in 2.5% Triton X100 (Sigma Aldrich), incubated for 16 h at 37°C in assay buffer (100 mM Tris, 30 mM CaCl 2 , 0.02% [wt/vol], sodium azide, 0.05% [vol/vol]; Brij 35, pH 7.9) and stained with Coomassie brilliant blue G for 20 min and destained in 1% acetic acid and 30% methanol.
Primary cell assays. Keratinocytes and dermal fibroblasts were isolated from neonatal mice mouse skin as described previously (Emmerson et al., 2009) . Mouse macrophages were isolated by peritoneal lavage with PBS and cultured as described previously (Emmerson et al., 2009) . Functional assays were performed in phenol red-free media containing charcoalstripped serum and mitomycin C where appropriate. Fibroblasts were cultured in PSAsupplemented DMEM (Lonza) and keratinocytes in CnT02 media (CELLnTEC) at 35°C and 5% CO 2 . Treatments (10 7 M 17estradiol, 10 6 M PPT, 10 6 M DPN, 10 7 M ICI 182780, 10 5 M MPP dihydro chloride, 10 5 M PHTPP) were consistent across all assays.
Scratch migration assay. Fibroblast or keratinocyte sheets were scratch wounded (sterile pipette tip) and immediately treated. Cells were incubated in serum and PSAsupplemented DMEM (Lonza) or CnT02 media (CELLnTEC) at either 37°C or 35°C and 5% CO 2 for 24 h (fibroblasts) or 48 h (keratinocytes). Images were captured on a microscope (Eclipse E600; Nikon) with a SPOT camera and software (Image Solutions Inc.), and degree of cell migration was determined using Image ProPlus software (Media Cybernetics). Proliferation assay. Fibroblasts or keratinocytes were seeded in 96well plates at a density of 5 × 10 3 cells/well. Cells were incubated for 48 h (keratinocytes) or 96 h (fibroblasts) and proliferation measured using the CellTiter96 AQ ueous MTSbased kit (Promega) relative to a calibration curve determined from wells known to contain between 5 × 10 3 and 10 5 fibroblasts.
Attachment assay. Keratinocytes were incubated at 37°C and 5% CO 2 for 3 h in uncoated or collagen IV-coated (BD) 12well plates. Unattached cells were removed by PBS washes. Attached keratinocytes were stained with 2% crystal violet and quantified using Image ProPlus software (Media Cybernetics).
Contraction assay. The contractile activity of dermal fibroblasts was as sessed using an established contraction assay (Emmerson et al., 2009 ). In brief, 1.5 × 10 6 cells/ml were resuspended in chilled collagen I matrix/ DMEM solution (Vitrogen 100). Aliquots of this cell/collagen/DMEM solution were incubated for 1 h under mineral oil in a Teflonlined, diecut obtained by crossing ER L2/L2 mice with the previously characterized LysMcre line (Clausen et al., 1999) . In each case, Crenegative homozygous floxed mice were used as littermate controls. 10wkold female C57/BL6 mice with intact ovaries and 10wkold C57/BL6 mice that had undergone ovariectomy 1 mo previously were wounded (two equidistant 1cm full thickness skin incisional wounds left to heal by secondary intention or two 6mm excisional wounds to temporally monitor healing) following our es tablished protocol (Emmerson et al., 2009) . PPT (4, 4', 4"(4Propyl[1H] pyrazole1,3,5triyl; Tocris), DPN (2,3bis(4Hydroxyphenyl)propionitrile; Tocris), or vehicle (5% DMSO in maize oil) was injected at 330 µg/kg/day on days 1, 0, and +1 with respect to time of wounding. Female ER / , ER / , K14cre/ER L2/L2 , K14cre/ER L2/L2 , LysMcre/ER L2/L2 , and WT littermates were also ovariectomised and wounded as above. Exogenous estrogen was administered at the time of wounding by s.c. implantation of a 0.05mg, 21d, slowrelease 17estradiol pellet (Innovative Research of America) with successful estrogen replacement confirmed by enzyme immuno assay on serum samples.
Histology and immunohistochemistry. Histological sections were pre pared from wound tissue fixed in 10% buffered formalin saline and embed ded in paraffin. 6µm sections were stained with hematoxylin and eosin, Sirius red (in picric acid), or subjected to immunohistochemical analysis with the following antibodies: antiER rabbit polyclonal (Santa Cruz Biotechnology, Inc.); mouse monoclonal antiER (AbD Serotec); anti neutrophil rat polyclonal (Thermo Fisher Scientific); anti-Mac3 rat poly clonal (BD); and anti-SMA rabbit polyclonal (SigmaAldrich). Bound primary antibody was detected using the VECTASTAIN ABC kit (Vector Laboratories), NovaRed substrate, and counterstained with hematoxylin. Images were captured using a microscope (Eclipse E600; Nikon) and a SPOT camera (Image Solutions Inc.) and total cell numbers, granulation tissue wound area, and reepithelialization were quantified using Image Pro Plus software (Media Cybernetics). Specifically, reepithelialization was de termined by dividing the sum length of both neoepithelial tongues by the distance the epidermis would have to migrate to fully close the wound. PicroSirius red staining was visualized using planepolarized light where larger collagen fibers appear red, orange, or yellow and thinner fibers green. Excisional wound closure was determined from planimetry of macroscopic wound images.
Quantitative real-time PCR (qPCR). Total RNA was isolated from frozen wound tissue by homogenizing in Trizol reagent (Invitrogen) or from cultured macrophages using the RNeasy mini kit (QIAGEN) with cDNA synthesis, and qPCR was performed as described previously (Gilliver et al., 2007 ; SYBR Green core kit; Eurogentec). Each sample was serially diluted over three orders of magnitude, and expression ratios normalized to the mean of three separate reference primers (18s rRNA, Gapdh, and Ywahz) with all samples analyzed concurrently. Full primer sequences are listed in Table S1 . 
